30
May
2007
Two beautiful new Colorado websites can be found… Taligen Therapeutics, Inc., new website (here), is a development stage biotechnology company with a novel technology to modulate and regulate activation of the complement system. An IND for their lead product, TA106 for persistent asthma, should hopefully be filed by 4Q07. And at 578 acres, the Fitzsimons [...]